The role of STAT3 in liver regeneration

Drugs of Today

Volumn 41, Issue 7, 2005, Pages 461-469

  Terui, Keita ^a,c   Ozaki, Michitaka ^b,c  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; CELL CYCLE; DNA SYNTHESIS; GENE EXPRESSION; GENE TARGETING; LIVER PROTECTION; LIVER REGENERATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; LIVER REGENERATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26844508371     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.7.893622     Document Type: Review

References (109)

1. Michalopoulos, G.K., DeFrances, M.C. Liver regeneration. Science 1997, 276: 60-6.
2. Fausto, N. Liver regeneration: From laboratory to clinic. Liver Transpl 2001, 7: 835-44.
3. Kountouras, J., Boura, P., Lygidakis, N.J. Liver regeneration after hepatectomy. Hepatogastroenterology 2001, 48: 556-62.
4. Higgins, G.M., Anderson, R.M. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931, 12: 186-202.
5. Grisham, J.W. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver, autoradiography with thymidine-h3. Cancer Res 1962, 22: 842-9.
6. Fausto, N. Liver regeneration. J Hepatol 2000, 32: 19-31.
7. Mangnall, D., Bird, N.C., Majeed, A.W. The molecular physiology of liver regeneration following partial hepatectomy. 2003, 23: 124-38.
8. Steer, C.J. Liver regeneration. FASEB J 1995, 9: 1396-400.
9. Fausto, N., Mead, J.E. Regulation of liver growth: Protooncogenes and transforming growth factors. Lab Invest 1989, 60: 4-13.
10. Fausto, N., Laird, A.D., Webber, E.M. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995, 9: 1527-36.
11. Lambotte, L., Saliez, A., Triest, S., Tagliaferri, E.M., Barker, A.P., Baranski, A.G. Control of rate and extent of the proliferative response after partial hepatectomy. Am J Physiol 1997, 273: 0905-12.
12. Naka, T., Nishimoto, N., Kishimoto, T. The paradigm of IL-6: From basic science to medicine. 2002, 4 (Suppl. 3): S233-42.
13. Ohira, H., Miyata, M., Kuroda, M. et al. Interleukin-6 induces proliferation of rat hepatocytes in vivo. J Hepatol 1996, 25: 941-7.
14. Taub, R., Greenbaum, L.E., Peng, Y. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 1999, 19: 117-27.
15. Schoen, J.M., Wang, H.H., Minuk, G.Y., Lautt, W.W. Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 2001, 5: 453-64.
16. Diehl, A.M. Cytokine regulation of liver injury and repair. Immunol Rev 2000, 174: 160-71.
17. Trautwein, C., Boker, K., Manns, M.P. Hepatocyte and immune system: Acute phase reaction as a contribution to early defence mechanisms. Gut 1994, 35: 1163-6.
18. Plumpe, J., Streetz, K., Manns, M.P., Trautwein, C. Tumour necrosis factor alpha-mediator of apoptosis and cell proliferation of hepatocytes. Ital J Gastroenterol Hepatol 1999, 31: 235-43.
19. Heinrich, P.C., Castell, U.V., Andus, T. Interleukin-6 and the acute phase response. Biochem J 1990, 265: 621-36.
20. Akerman, P., Cote, P., Yang, S.Q. et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992, 263: G579-85.
21. Rai, R.M., Yang, S.O., McClain, C., Karp, C.L., Klein, A.S., Diehl, A.M. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am J Physiol 1996, 270: G909-18.
22. Matsunami, H., Kawasaki, S., Ishizone, S. et al. Serial changes of h-HGF and IL-6 in living-related donor liver transplantation with special reference to their relationship to intraoperative portal blood flow. Transplant Proc 1992, 24: 1971-2.
23. Galun, E., Zeira, E., Pappo, O., Peters, M., Rose-John, S. Liver regeneration induced by a designer human IL-6/SIL-6R fusion protein reverses severe hepatocellular injury. FASEB J 2000, 14: 1979-87.
24. Yamada, Y., Kirillova, I., Peschon, J.J., Fausto, N. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997, 94: 1441-6.
25. Yamada, Y., Webber, E.M., Kirillova, I., Peschon, J.J., Fausto, N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 1998, 28: 959-70.
26. Yamada, Y., Fausto, N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 1998, 152: 1577-89.
27. Cressman, D.E., Greenbaum, L.E., DeAngelis, R.A. et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996, 274: 1379-83.
28. Sakamoto, T., Liu, Z., Murase, N. et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999, 29: 403-11.
29. Wallenius, V., Wallenius, K., Hisaoka, M. et al. Retarded liver growth in interleukin-6-deficient and tumor necrosis factor receptor-1-deficient mice. Endocrinology 2001, 142: 2953-60.
30. Brenner, D.A. Signal transduction during liver regeneration. J Gastroenterol Hepatol 1998, 13 (Suppl.): S93-5.
31. Galun, E., Axelrod, J.H. The role of cytokines in liver failure and regeneration: Potential new molecular therapies. Biochim Biophys Acta 2002, 1592: 345-58.
32. Streetz, K.L., Luedde, T., Manns, M.P., Trautwein, C. Interleukin 6 and liver regeneration. Gut 2000, 47: 309-12.
33. Zimmers, T.A., McKillop, I.H., Pierce, R.H., Yoo, J.Y., Koniaris, L.G. Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology 2003, 38: 326-34.
34. Peters, M., Blinn, G., Jostock, T. et al. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 2000, 119: 1663-71.
35. Selzner, M., Camargo, C.A., Clavien, P.A. Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of interleukin-6. Hepatology 1999, 30: 469-75.
36. Wuestefeld, T., Klein, C., Streetz, K.L. et al. Interleukin-6/ glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003, 278: 11281-8.
37. Yasukawa, H., Sasaki, A., Yoshimura, A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000, 18: 143-64.
38. Bradham, C.A., Plumpe, J., Manns, M.P., Brenner, D.A., Trautwein, C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 1998, 275: G387-92.
39. Sakuda, S., Tamura, S., Yamada, A. et al. Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats. J Hepatol 2002, 36: 378-84.
40. Aldeguer, X., Debonera, F., Shaked, A. et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002, 35: 40-8.
41. Cornell, R.P. Endotoxin-induced hyperinsulinemia and hyperglucagonemia after experimental liver injury. Am J Physiol 1981, 241: E428-35.
42. Cornell, R.P., Liljequist, B.L., Bartizal, K.F. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 1990, 11: 916-22.
43. Meijer, C., Wiezer, M.J., Diehl, A.M. et al. Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. Liver 2000, 20: 66-77.
44. Darnell, J.E. STATs and gene regulation. Science 1997, 277: 1630-5.
45. Schuringa, J.J., Jonk, L.J., Dokter, W.H., Vellenga, E., Kruijer, W. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Biochem J 2000, 347 (Pt. 1): 89-96.
46. Leu, J.I., Crissey, M.A., Leu, J.P., Ciliberto, G., Taub, R. Interleukin-6-induced STAT3 and AP1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 2001, 21: 414-24.
47. Schuringa, J.J., van der Schaaf, S., Vellenga, E., Eggen, B.J., Kruijer, W. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells. Exp Cell Res 2002, 274: 119-29.
48. Levy, D.E., Lee, C.K. What does STAT3 do? J Clin Invest 2002, 109: 1143-8.
49. Lutticken, C., Wegenka, U.M., Yuan, J. et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994, 263: 89-92.
50. Darnell, J.E., Kerr, I.M., Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264: 1415-21.
51. Bromberg, J., Darnell, J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19: 2468-73.
52. Cressman, D.E., Diamond, R.H., Taub, R. Rapid activation of the STAT3 transcription complex in liver regeneration. Hepatology 1995, 21: 1443-9.
53. Trautwein, C., Rakemann, T., Niehof, M., Rose-John, S., Manns, M.P. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology 1996, 110: 1854-62.
54. Takeda, K., Noguchi, K., Shi, W. et al. Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997, 94: 3801-4.
55. Debonera, F., Aldeguer, X., Shen, X. et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J Surg Res 2001, 96: 289-95.
56. Li, W., Liang, X., Kellendonk, C., Poli, V., Taub, R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002, 277: 28411-7.
57. Sherr, C.J. G1 phase progression: Cycling on cue. Cell 1994, 79: 551-5.
58. Menjo, M., Ikeda, K., Nakanishi, M. Regulation of G1 cyclin-dependent kinases in liver regeneration. J Gastroenterol Hepatol 1998, 13 (Suppl.): S100-5.
59. Lu, X.P., Koch, K.S., Lew, D.J. et al. Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J Biol Chem 1992, 267: 2841-4.
60. Albrecht, J.H., Hoffman, J.S., Kren, B.T., Steer, C.J. Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases. Am J Physiol 1993, 265: 0857-64.
61. Loyer, P., Cariou, S., Glaise, D., Bilodeau, M., Baffet, G., Guguen-Guillouzo, C. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem 1996, 271: 11484-92.
62. Motokura, T., Arnold, A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993, 3: 5-10.
63. Zhang, Y.J., Jiang, W., Chen, C.J. et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993, 196: 1010-6.
64. Peters, G. The D-type cyclins and their role in tumorigenesis. J Cell Sci Suppl 1994, 18: 89-96.
65. Arnold, A. The cyclin D1/PRAD1 oncogene in human neoplasia. J Investig Med 1995, 43: 543-9.
66. Nishida, N., Fukuda, Y., Ishizaki, K., Nakao, K. Alteration of cell cycle-related genes in hepatocarcinogenesis. Histol Histopathol 1997, 12: 1019-25.
67. Kitamura, T., Watanabe, S., Sato, N. Liver regeneration, liver cancers and cyclins. J Gastroenterol Hepatol 1998, 13 (Suppl.): S96-9.
68. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G. et al. STAT3 as an oncogene. Cell 1999, 98: 295-303.
69. Matsumura, I., Kitamura, T., Wakao, H. et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J 1999, 18: 1367-77.
70. Fukada, T., Ohtani, T., Yoshida, Y. et al. ST/473 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 1998, 17: 6670-7.
71. Albrecht, J.H., Hansen, L.K. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ 1999, 10: 397-404.
72. Hansen, L.K., Albrecht, J.H. Regulation of the hepatocyte cell cycle by type I collagen matrix: Role of cyclin D1. J Cell Sci 1999, 112 (Pt. 17): 2971-81.
73. Nelsen, C.J., Rickheim, D.G., Timchenko, N.A., Stanley, M.W., Albrecht, J.H. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res 2001, 61: 8564-8.
74. Nelsen, C.J., Rickheim, D.G., Tucker, M.M., Hansen, L.K., Albrecht, J.H. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem 2003, 278: 3656-63.
75. Nelsen, C.J., Rickheim, D.G., Tucker, M.M. et al. Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. J Biol Chem 2003, 278: 25853-8.
76. Rickheim, D.G., Nelsen, C.J., Fassett, J.T., Timchenko, N.A., Hansen, L.K., Albrecht, J.H. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation. Hepatology 2002, 36: 30-8.
77. Malumbres, M., Barbacid, M. To cycle or not to cycle: A critical decision in cancer. 2001, 1: 222-31.
78. Sherr, C.J. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000, 60: 3689-95.
79. Sears, R.C., Nevins, J.R. Signaling networks that link cell proliferation and cell fate. J Biol Chem 2002, 277: 11617-20.
80. Couttant, A., Rescan, C., Gilot, D., Loyer, P., Guguen-Guillouzo, C., Baffet, G. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 2002, 36: 1079-88.
81. Thompson, N.L., Mead, J.E., Braun, L., Goyette, M., Shank, P.R., Fausto, N. Sequential proto-oncogene expression during rat liver regeneration. Cancer Res 1986, 46: 3111-7.
82. Lau, L.F., Nathans, D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 1985, 4: 3145-51.
83. Lau, L.F., Nathans, D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 1987, 84: 1182-6.
84. Almendral, J.M., Sommer, D., Macdonald-Bravo, H., Burckhardt, J., Perera, J., Bravo, R. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 1988, 8: 2140-8.
85. Zipfel, P.F., Irving, S.G., Kelly, K., Siebenlist, U. Complexity of the primary genetic response to mitogenic activation of human T cells. Mol Cell Biol 1989, 9: 1041-8.
86. Herschman, H.R. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 1991, 60: 281-319.
87. Arai, M., Yokosuka, O., Chiba, T. et al. Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem 2003, 278: 29813-8.
88. Su, A.I., Guidotti, L.G., Pezacki, J.P., Chisari, F.V., Schultz, P.G. Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci USA 2002, 99: 11181-6.
89. Mohn, K.L., Laz, T.M., Melby, A.E., Taub, R. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families. J Biol Chem 1990, 265: 21914-21.
90. Mohn, K.L., Laz, T.M., Hsu, J.C., Melby, A.E., Bravo, R., Taub, R. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: Comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol 1991, 11: 381-90.
91. Mohn, K.L., Melby, A.E., Tewari, D.S., Laz, T.M., Taub, R. The gene encoding rat insulinlike growth factor-binding protein 1 is rapidly and highly induced in regenerating liver. Mol Cell Biol 1991, 11: 1393-401.
92. Goyette, M., Petropoulos, C.J., Shank, P.R., Fausto, N. Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver. Mol Cell Biol 1984, 4: 1493-8.
93. Haber, B.A., Mohn, K.L., Diamond, R.H., Taub, R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993, 91: 1319-26.
94. Zhong, Z., Wen, Z., Darnell, J.E. STAT3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264: 95-8.
95. Zhong, Z., Wen, Z., Darnell, J.E. STAT3 and STAT4: Members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 1994, 91: 4806-10.
96. Hayes, T.E., Kitchen, A.M., Cochran, B.H. Inducible binding of a factor to the c-fos regulatory region. Proc Natl Acad Sci USA 1987, 84: 1272-6.
97. Sacca, R., Cochran, B.H. Identification of a PDGF-responsive element in the murine c-myc gene. Oncogene 1990, 5: 1499-505.
98. Wagner, B.J., Hayes, I.E., Hoban, C.J., Cochran, B.H. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990, 9: 4477-84.
99. Taub, R. Liver regeneration 4: Transcriptional control of liver regeneration. FASEB J 1996, 10: 413-27.
100. Taub, R. Liver regeneration in health and disease. Clin Lab Med 1996, 16: 341-60.
101. FitzGerald, M.J., Webber, E.M., Donovan, J.R., Fausto, N. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ 1995, 6: 417-27.
102. Cressman, D.E., Greenbaum, L.E., Haber, B.A., Taub, R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994, 269: 30429-35.
103. Soriano, H.E., Bilyeu, T.A., Juan, T.S., Zhao, W., Darlington, G.J. DNA binding by C/EBP proteins correlates with hepatocyte proliferation. In Vitro Cell Dev Biol Anim 1995, 31: 703-9.
104. Aoki, Y., Feldman, G.M., Tosato, G. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003, 101: 1535-42.
105. Konnikova, L., Kotecki, M., Kruger, M.M., Cochran, B.H. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 2003, 3: 23.
106. Mahboubi, K., Li, F., Plescia, J. et al. Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest 2001, 81: 327-34.
107. Haga, S., Terui, K., Zhang, H.Q. et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003, 112: 989-98.
108. Terui, K., Enosawa, S., Haga, S. et al. Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD. J Hepatol 2004, 41: 957-65.
109. Negoro, S., Kunisada, K., Fujio, Y. et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001, 104: 979-81.